Tonix Pharmaceuticals (TNXP) Stock: Why It's Down Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
- Trading at $5.73 as of 12:05 PM ET, -5.13% vs the prior close of $6.04.
- Volume 511.71K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TNXP slides 5.1% to $5.73, a 52-week low. Trading at $5.73 (intraday, 12:05 PM ET), -5.13% vs the prior close of $6.04. Day range $5.73–$6.22, opened at $6.16.
TNXP daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — TNXP slides 5.1% to $5.73, a 52-week low
- Trading at $5.73 (intraday, 12:05 PM ET), -5.13% vs the prior close of $6.04. Day range $5.73–$6.22, opened at $6.16.
- Volume was 511.71K shares, 0.8x its 50-day average of 654.95K.
- Price is -47.1% vs its 50-day average ($10.83) and -55.7% vs its 200-day average ($12.94).
- 52-week range $5.73–$20.58; the current price sits at 0% of that range, 72.2% below the 52-week high.
Oct 16, 2026 — TNXP slides 5.9% to $6.04, a 52-week low
- Closed at $6.04, -5.92% vs the prior close of $6.42. Day range $6.02–$6.56, opened at $6.46.
- Volume was 929.64K shares, 1.5x its 50-day average of 640.80K.
- Price is -44.9% vs its 50-day average ($10.95) and -53.5% vs its 200-day average ($12.99).
- 52-week range $6.01–$20.69; today's close sits at 0% of that range, 70.8% below the 52-week high.
Oct 15, 2026 — TNXP rises 0.3% to $6.42 on 4.0x normal volume
- Closed at $6.42, +0.31% vs the prior close of $6.40. Day range $6.28–$6.69, opened at $6.50.
- Volume was 2.40M shares, 4.0x its 50-day average of 598.06K — unusually heavy trading.
- Price is -42.0% vs its 50-day average ($11.06) and -50.8% vs its 200-day average ($13.04).
- 52-week range $6.01–$20.69; today's close sits at 3% of that range, 69.0% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 14, 2026 — TNXP jumps 4.4% to $6.40 on 2.4x normal volume
- Closed at $6.40, +4.40% vs the prior close of $6.13. Day range $6.01–$6.72, opened at $6.03.
- Volume was 1.39M shares, 2.4x its 50-day average of 577.50K — unusually heavy trading.
- Price is -42.7% vs its 50-day average ($11.16) and -51.1% vs its 200-day average ($13.09).
- 52-week range $6.01–$20.69; today's close sits at 3% of that range, 69.1% below the 52-week high.
Oct 13, 2026 — TNXP slides 7.7% to $6.13, a 52-week low on 2.0x normal volume
- Closed at $6.13, -7.68% vs the prior close of $6.64. Day range $6.11–$6.68, opened at $6.61.
- Volume was 1.13M shares, 2.0x its 50-day average of 561.77K — unusually heavy trading.
- Price is -45.5% vs its 50-day average ($11.26) and -53.3% vs its 200-day average ($13.14).
- 52-week range $6.11–$20.69; today's close sits at 0% of that range, 70.4% below the 52-week high.
Oct 12, 2026 — TNXP slides 9.0% to $6.64, a 52-week low
- Closed at $6.64, -9.04% vs the prior close of $7.30. Day range $6.64–$7.28, opened at $7.24.
- Volume was 958.00K shares, 1.7x its 50-day average of 551.98K.
- Price is -41.5% vs its 50-day average ($11.35) and -49.7% vs its 200-day average ($13.19).
- 52-week range $6.64–$22.38; today's close sits at 0% of that range, 70.3% below the 52-week high.
Oct 9, 2026 — TNXP ends flat (+0.3%) to $7.30
- Closed at $7.30, +0.27% vs the prior close of $7.28. Day range $7.09–$7.54, opened at $7.27.
- Volume was 960.90K shares, 1.8x its 50-day average of 539.33K.
- Price is -36.1% vs its 50-day average ($11.42) and -44.9% vs its 200-day average ($13.24).
- 52-week range $7.09–$23.06; today's close sits at 1% of that range, 68.3% below the 52-week high.
Oct 8, 2026 — TNXP slides 3.6% to $7.28, a 52-week low on 2.1x normal volume
- Closed at $7.28, -3.58% vs the prior close of $7.55. Day range $7.16–$7.72, opened at $7.46.
- Volume was 1.09M shares, 2.1x its 50-day average of 528.36K — unusually heavy trading.
- Price is -36.5% vs its 50-day average ($11.47) and -45.2% vs its 200-day average ($13.29).
- 52-week range $7.16–$23.25; today's close sits at 1% of that range, 68.7% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — TNXP dips 1.9% to $7.55, a 52-week low, 5 down days in a row
- Closed at $7.55, -1.95% vs the prior close of $7.70. Day range $7.42–$7.79, opened at $7.70.
- Volume was 708.10K shares, 1.4x its 50-day average of 523.23K.
- Price is -34.4% vs its 50-day average ($11.52) and -43.4% vs its 200-day average ($13.34).
- 52-week range $7.42–$24.49; today's close sits at 1% of that range, 69.2% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — TNXP slides 4.6% to $7.70, a 52-week low on 5.3x normal volume
- Closed at $7.70, -4.58% vs the prior close of $8.07. Day range $7.69–$8.33, opened at $8.15.
- Volume was 2.54M shares, 5.3x its 50-day average of 480.57K — unusually heavy trading.
- Price is -33.4% vs its 50-day average ($11.56) and -42.5% vs its 200-day average ($13.39).
- 52-week range $7.69–$24.67; today's close sits at 0% of that range, 68.8% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — TNXP slides 9.4% to $8.07, a 52-week low on 2.4x normal volume
- Closed at $8.07, -9.43% vs the prior close of $8.91. Day range $8.00–$8.82, opened at $8.82.
- Volume was 1.14M shares, 2.4x its 50-day average of 472.09K — unusually heavy trading.
- Price is -30.5% vs its 50-day average ($11.62) and -40.0% vs its 200-day average ($13.44).
- 52-week range $8.00–$25.40; today's close sits at 0% of that range, 68.2% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — TNXP slides 3.5% to $8.91, a 52-week low
- Closed at $8.91, -3.47% vs the prior close of $9.23. Day range $8.69–$9.56, opened at $9.38.
- Volume was 802.60K shares, 1.7x its 50-day average of 463.63K.
- Price is -23.5% vs its 50-day average ($11.65) and -34.0% vs its 200-day average ($13.50).
- 52-week range $8.69–$25.40; today's close sits at 1% of that range, 64.9% below the 52-week high.
- SEC filings that day: 8-K.
TNXP bull case vs bear case (from the data)
- Annual revenue grew 29.8% in the latest fiscal year (SEC XBRL).
- Insiders made 25 open-market purchases in the last 12 months.
- Price is -47.1% vs its 50-day average — short-term trend is down.
- Price is -55.7% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $124.02M.
- Share count up 95.7% in a year (dilution).
- High volatility: average daily move of 3.8% over 20 sessions.
TNXP latest news & SEC filings
Every SEC filing by or about TNXP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 8, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lederman Seth bought 2,000 shares at $13.79 (≈$27.58K) on Aug 27, 2026
- Lederman Seth bought 2,000 shares at $13.79 (≈$27.58K) on Aug 27, 2026
- Lederman Seth bought 2,000 shares at $13.79 (≈$27.58K) on Aug 27, 2026
- Lederman Seth bought 2,000 shares at $13.79 (≈$27.58K) on Aug 27, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bagger Richard H bought 1,000 shares at $12.60 (≈$12.60K) on Aug 20, 2026
- Bagger Richard H bought 1,000 shares at $12.60 (≈$12.60K) on Aug 20, 2026
- Bagger Richard H bought 1,000 shares at $12.60 (≈$12.60K) on Aug 20, 2026
- Bagger Richard H bought 1,000 shares at $12.60 (≈$12.60K) on Aug 20, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $13.54M (prior year $2.00M) (+577.9% vs Jun 30, 2025)
- Net income: -$40.55M (prior year -$28.27M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$2.44 (prior year -$3.86) (loss narrowed vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Jul 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade TNXP
- Last results release: Oct 15, 2026 (8-K Item 2.02). Previous ones: Aug 10, 2026, May 11, 2026, May 1, 2026. Based on that rhythm, the next report is likely around Jan 14, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.82% (largest 9.4%). That is a volatile stock.
- Liquidity: about 929.20K shares (≈$5.32M) trade per day on average.
- 52-week position: $5.73 vs a range of $5.73–$20.58 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:100 on Feb 5, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Seth Lederman bought 2,000 shares on Aug 27, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 2, 2026; 8-K Sep 22, 2026.
- Share count: 17.15M shares outstanding (Aug 7, 2026), +95.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
TNXP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 6.16 | 6.22 | 5.73 | 5.73 | 511.71K |
| Oct 16, 2026 | 6.46 | 6.56 | 6.02 | 6.04 | 934.90K |
| Oct 15, 2026 | 6.50 | 6.69 | 6.28 | 6.42 | 2.40M |
| Oct 14, 2026 | 6.03 | 6.72 | 6.01 | 6.40 | 1.39M |
| Oct 13, 2026 | 6.61 | 6.68 | 6.11 | 6.13 | 1.13M |
| Oct 12, 2026 | 7.24 | 7.28 | 6.64 | 6.64 | 958.00K |
| Oct 9, 2026 | 7.27 | 7.54 | 7.09 | 7.30 | 960.90K |
| Oct 8, 2026 | 7.46 | 7.72 | 7.16 | 7.28 | 1.09M |
| Oct 7, 2026 | 7.70 | 7.79 | 7.42 | 7.55 | 708.10K |
| Oct 6, 2026 | 8.15 | 8.33 | 7.69 | 7.70 | 2.54M |
| Oct 5, 2026 | 8.82 | 8.82 | 8.00 | 8.07 | 1.14M |
| Oct 2, 2026 | 9.38 | 9.56 | 8.69 | 8.91 | 802.60K |
| Oct 1, 2026 | 9.65 | 9.69 | 9.19 | 9.23 | 475.00K |
| Sep 30, 2026 | 9.62 | 9.92 | 9.57 | 9.74 | 317.50K |
| Sep 29, 2026 | 9.98 | 10.08 | 9.56 | 9.65 | 393.70K |
| Sep 28, 2026 | 9.77 | 10.05 | 9.70 | 9.90 | 342.20K |
| Sep 25, 2026 | 9.80 | 9.90 | 9.62 | 9.86 | 380.50K |
| Sep 24, 2026 | 10.23 | 10.23 | 9.64 | 9.70 | 613.30K |
| Sep 23, 2026 | 10.59 | 10.84 | 9.96 | 10.24 | 913.50K |
| Sep 22, 2026 | 10.93 | 11.19 | 10.49 | 10.59 | 584.90K |
About Tonix Pharmaceuticals
Tonix Pharmaceuticals (TNXP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BERKELEY HEIGHTS, NJ. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1430306.
TNXP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Richard H Bagger | Director | Aug 24, 2026 |
| Margaret Smith Bell | Director | May 14, 2026 |
| David L Grange | Director | May 14, 2026 |
| James Randolph Jr Hunter | Director | May 14, 2026 |
| Seth Lederman | Chief Executive Officer | Aug 31, 2026 |
| Adeoye Y Olukotun | Director | May 14, 2026 |
| Richard Newcomb Stillwell | Director | Jun 9, 2026 |
| Carolyn E. Taylor | Director | Jun 15, 2026 |
| James Treco | Director | May 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Thomas Englese | Chief Commercial Officer | Sep 8, 2026 |
| Siobhan Fogarty | Chief Technology Officer | Feb 26, 2026 |
| Seth Lederman | Chief Executive Officer | Aug 31, 2026 |
| Jessica Edgar Morris | Chief Operating Officer | Feb 26, 2026 |
| Bradley Saenger | Chief Financial Officer | Jul 9, 2026 |
| Gregory M Sullivan | Chief Medical Officer | Feb 26, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 27, 2026 | Seth Lederman | Buy | 2,000 | $13.79 |
| Aug 27, 2026 | Seth Lederman | Buy | 2,000 | $13.79 |
| Aug 27, 2026 | Seth Lederman | Buy | 2,000 | $13.79 |
| Aug 27, 2026 | Seth Lederman | Buy | 2,000 | $13.79 |
| Aug 20, 2026 | Richard H Bagger | Buy | 1,000 | $12.60 |
| Aug 20, 2026 | Richard H Bagger | Buy | 1,000 | $12.60 |
| Aug 20, 2026 | Richard H Bagger | Buy | 1,000 | $12.60 |
| Aug 20, 2026 | Richard H Bagger | Buy | 1,000 | $12.60 |
| Jun 12, 2026 | Carolyn E. Taylor | Buy | 1,415 | $10.55 |
| Jun 12, 2026 | Carolyn E. Taylor | Buy | 1,415 | $10.55 |
| Jun 12, 2026 | Carolyn E. Taylor | Buy | 1,415 | $10.55 |
| Jun 12, 2026 | Carolyn E. Taylor | Buy | 1,415 | $10.55 |
| Jun 9, 2026 | Seth Lederman | Buy | 5,000 | $11.79 |
| Jun 9, 2026 | Seth Lederman | Buy | 5,000 | $11.79 |
| Jun 9, 2026 | Seth Lederman | Buy | 5,000 | $11.79 |
TNXP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $13.11M | $-124.02M | -14.57 | $-99.84M |
| Dec 31, 2024 | $10.09M | $-130.04M | -176.60 | $-60.92M |
| Dec 31, 2023 | $7.77M | $-116.66M | -14,720.25 | $-102.00M |
| Dec 31, 2022 | — | $-110.22M | -20.01 | $-98.05M |
| Dec 31, 2021 | — | $-92.29M | -8.10 | $-75.56M |
Latest balance sheet: total assets $254.09M, total liabilities $31.81M, cash $176.23M (as of Jun 30, 2026).
TNXP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 15, 2026 | 8-K Item 2.02 (results) | $6.42 |
| Aug 10, 2026 | 8-K Item 2.02 (results) | $12.59 |
| May 11, 2026 | 8-K Item 2.02 (results) | $14.11 |
| May 1, 2026 | 8-K Item 2.02 (results) | $13.60 |
| Mar 13, 2026 | 8-K Item 2.02 (results) | $13.24 |
| Feb 3, 2026 | 8-K Item 2.02 (results) | $17.16 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $16.84 |
| Oct 27, 2025 | 8-K Item 2.02 (results) | $20.35 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $44.97 |
| Jul 25, 2025 | 8-K Item 2.02 (results) | $49.73 |
| May 12, 2025 | 8-K Item 2.02 (results) | $19.19 |
| Apr 25, 2025 | 8-K Item 2.02 (results) | $17.82 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on TNXP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.